Akebia Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, and thanks again for joining the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. Our next presenting company is Akebia Therapeutics, and it's my pleasure to welcome John Butler, CEO, to talk to us a little bit about the company. There is a Q&A session after the presentation. Feel free to make questions, and I'll work them in where appropriate.
With that, John, thanks for sharing some of your time with us this afternoon.
Eric, thank you so much for the invitation. It really is a pleasure to be here to have the opportunity to talk to you today about Akebia, where we really are a purpose-driven company, and our purpose is to better the life of each person impacted by kidney disease. I just want to remind everyone that I'm going to be making forward-looking statements. So please refer to our SEC filings for more information.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
